These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

148 related articles for article (PubMed ID: 17721279)

  • 1. Development of standard estrogen and progesterone receptor immunohistochemical assays for selection of patients for antihormonal therapy.
    Phillips T; Murray G; Wakamiya K; Askaa J; Huang D; Welcher R; Pii K; Allred DC
    Appl Immunohistochem Mol Morphol; 2007 Sep; 15(3):325-31. PubMed ID: 17721279
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Re-evaluating adjuvant breast cancer trials: assessing hormone receptor status by immunohistochemical versus extraction assays.
    Regan MM; Viale G; Mastropasqua MG; Maiorano E; Golouh R; Carbone A; Brown B; Suurküla M; Langman G; Mazzucchelli L; Braye S; Grigolato P; Gelber RD; Castiglione-Gertsch M; Price KN; Coates AS; Goldhirsch A; Gusterson B;
    J Natl Cancer Inst; 2006 Nov; 98(21):1571-81. PubMed ID: 17077359
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Quality assurance for detection of estrogen and progesterone receptors by immunohistochemistry in Austrian pathology laboratories.
    Regitnig P; Reiner A; Dinges HP; Höfler G; Müller-Holzner E; Lax SF; Obrist P; Rudas M; Quehenberger F
    Virchows Arch; 2002 Oct; 441(4):328-34. PubMed ID: 12404057
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Immunocytochemical determination of estrogen and progesterone receptors on 219 fine-needle aspirates of breast cancer. A prospective study.
    Marrazzo A; Taormina P; Leonardi P; Lupo F; Filosto S
    Anticancer Res; 1995; 15(2):521-6. PubMed ID: 7763033
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Comparison of different antibodies for detection of progesterone receptor in breast cancer.
    Press M; Spaulding B; Groshen S; Kaminsky D; Hagerty M; Sherman L; Christensen K; Edwards DP
    Steroids; 2002 Aug; 67(9):799-813. PubMed ID: 12123792
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Hormone receptor expression in invasive breast cancer among Korean women and comparison of 3 antiestrogen receptor antibodies: a multi-institutional retrospective study using tissue microarrays.
    Bae YK; Gong G; Kang J; Lee A; Cho EY; Lee JS; Suh KS; Lee DW
    Am J Surg Pathol; 2012 Dec; 36(12):1817-25. PubMed ID: 23154769
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Concordance between semiquantitative immunohistochemical assay and oncotype DX RT-PCR assay for estrogen and progesterone receptors.
    O'Connor SM; Beriwal S; Dabbs DJ; Bhargava R
    Appl Immunohistochem Mol Morphol; 2010 May; 18(3):268-72. PubMed ID: 20186046
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Expression of oestrogen receptor-beta in invasive breast tumours].
    Péter I; Számel I; Péley G
    Magy Onkol; 2004; 48(1):63-9. PubMed ID: 15105898
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Comparison of the oestrogen and progesterone receptor status in primary breast carcinomas as evaluated by immunohistochemistry and immunocytochemistry: a consecutive series of 267 patients.
    Domanski AM; Monsef N; Domanski HA; Grabau D; Fernö M
    Cytopathology; 2013 Feb; 24(1):21-5. PubMed ID: 22783929
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Solving the dilemma of the immunohistochemical and other methods used for scoring estrogen receptor and progesterone receptor in patients with invasive breast carcinoma.
    Fisher ER; Anderson S; Dean S; Dabbs D; Fisher B; Siderits R; Pritchard J; Pereira T; Geyer C; Wolmark N
    Cancer; 2005 Jan; 103(1):164-73. PubMed ID: 15565575
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Comparison of evaluations for hormone receptors in breast carcinoma using two manual and three automated immunohistochemical assays.
    Arihiro K; Umemura S; Kurosumi M; Moriya T; Oyama T; Yamashita H; Umekita Y; Komoike Y; Shimizu C; Fukushima H; Kajiwara H; Akiyama F
    Am J Clin Pathol; 2007 Mar; 127(3):356-65. PubMed ID: 17276950
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Estrogen receptor antibody incubation time and extent of immunoreactivity in invasive carcinoma of the breast: the importance of optimizing antibody avidity.
    Goldstein NS; Hunter S; Forbes S; Odish E; Tehrani M
    Appl Immunohistochem Mol Morphol; 2007 Jun; 15(2):203-7. PubMed ID: 17525635
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Comparison of the PharmDx immunohistochemical system with standard methods for assessing estrogen and progesterone receptors in invasive carcinoma of the breast.
    Gill MS; Paish EC; Ronan J; Green AR; Ellis IO; Lee AH
    Appl Immunohistochem Mol Morphol; 2013 Jan; 21(1):90-3. PubMed ID: 22820666
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Immunohistochemical detection of estrogen and progesterone receptors performed with an antigen-retrieval technique on methacarn-fixed paraffin-embedded breast cancer tissues.
    Oyaizu T; Arita S; Hatano T; Tsubura A
    J Surg Res; 1996 Jan; 60(1):69-73. PubMed ID: 8592434
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Semi-quantitative evaluation of estrogen receptor expression is a strong predictive factor of pathological complete response after anthracycline-based neo-adjuvant chemotherapy in hormonal-sensitive breast cancer.
    Petit T; Wilt M; Velten M; Rodier JF; Fricker JP; Dufour P; Ghnassia JP
    Breast Cancer Res Treat; 2010 Nov; 124(2):387-91. PubMed ID: 20824324
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Estimation of hormone receptor status and HER2 in cytologic cell blocks from breast cancer using the novel rabbit monoclonal antibodies (SP1, SP2, and SP3).
    Nassar A; Cohen C; Siddiqui M
    Diagn Cytopathol; 2009 Dec; 37(12):865-70. PubMed ID: 19530101
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Reliance on hormone receptor assays of surgical specimens may compromise outcome in patients with breast cancer.
    Mann GB; Fahey VD; Feleppa F; Buchanan MR
    J Clin Oncol; 2005 Aug; 23(22):5148-54. PubMed ID: 16051956
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Evaluation of new monoclonal antibodies in detection of estrogen receptor, progesterone receptor, and Her2 protein expression in breast carcinoma cell block sections using conventional microscopy and quantitative image analysis.
    Hanley KZ; Siddiqui MT; Lawson D; Cohen C; Nassar A
    Diagn Cytopathol; 2009 Apr; 37(4):251-7. PubMed ID: 19217031
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Estrogen receptor (ER) and progesterone receptor (PgR), by ligand-binding assay compared with ER, PgR and pS2, by immuno-histochemistry in predicting response to tamoxifen in metastatic breast cancer: a Southwest Oncology Group Study.
    Elledge RM; Green S; Pugh R; Allred DC; Clark GM; Hill J; Ravdin P; Martino S; Osborne CK
    Int J Cancer; 2000 Mar; 89(2):111-7. PubMed ID: 10754487
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Simultaneous immunohistochemical and biochemical hormone receptor assessment in breast cancer provides complementary prognostic information.
    Biesterfeld S; Schröder W; Steinhagen G; Koch R; Veuskens U; Schmitz FJ; Handt S; Böcking A
    Anticancer Res; 1997; 17(6D):4723-9. PubMed ID: 9494596
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.